SyqeAir Inhaler – Crohn's Disease
Crohn's Disease
CommercialActive
Key Facts
About Syqe Medical
Syqe Medical delivers precise, low‑dose medical cannabis via a patented metered‑dose inhaler for pain and other chronic conditions.
View full company profileTherapeutic Areas
Other Crohn's Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| Repositioned/Rerouted API | Reponex | Not Specified |
| PALI-2108 | Palisade Bio | Preclinical |
| TRX319 | Tr1X | Phase 1/2a |
| Budesonide capsules, 3mg | Sciecure Pharma | Approved |
| EXL01 | Exeliom Biosciences | Phase 2 |
| CVT12011965 | CVasThera | Pre-clinical |
| StroMel™ (Planned) | Akan Biosciences | Planned |
| omilancor | NImmune Biopharma | Phase 2 |
| Obefazimod (ABX464) | Abivax | Phase 3 |
| Icotrokinra (JNJ-2113) | Protagonist Therapeutics | Phase 2/3 |
| VTX002 | Ventyx Biosciences | Phase 2 |